Looks like you clickedhttps://www.globenewswire.com/news-release/2023/10/10/2757315/0/en/BioXcel-Therapeutics-Reports-Positive-Overall-Survival-Results-from-Single-Arm-Open-Label-Phase-2-Trial-of-BXCL701-in-Patients-with-Small-Cell-Neuroendocrine-Prostate-Cancer.html
If you do not want to visit that page, you can close this browser tab.
